TYK Medicines, Inc (Stock Code: 2410) Granted Drug Manufacturing License

Bulletin Express

01/23

TYK Medicines, Inc (浙江同源康醫藥股份有限公司) (Stock Code: 2410) announced that it has been granted the Drug Manufacturing License by the Drug Administration of Zhejiang Province. According to the announcement, the license carries the number “Zhejiang 20260002” and remains valid until January 22, 2031. The production address and range designate Asymchem Life Science (Tianjin) Co., Ltd. as trustee manufacturer at No. 71, 7th Street, Economic-Technological Development Area, Tianjin.

The announcement indicates that securing this license may facilitate the company’s capacity and market expansion, laying a foundation for subsequent commercial production of cancer-treatment products. Caution is noted under Rule 18A.05 of the Listing Rules, reminding shareholders and potential investors that there is no assurance the relevant product will ultimately be successfully developed or marketed.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1156381147"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1156381147\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1156381147?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-23 19:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156381147","market":"hk","top_or_hot":-1,"title":"TYK Medicines, Inc (Stock Code: 2410) Granted Drug Manufacturing License","media":"Bulletin Express","content":"<p>TYK Medicines, Inc (浙江同源康醫藥股份有限公司) (Stock Code: 2410) announced that it has been granted the Drug Manufacturing License by the Drug Administration of Zhejiang Province. According to the announcement, the license carries the number “Zhejiang 20260002” and remains valid until January 22, 2031. The production address and range designate Asymchem Life Science (Tianjin) Co., Ltd. as trustee manufacturer at No. 71, 7th Street, Economic-Technological Development Area, Tianjin.</p>\n<p>The announcement indicates that securing this license may facilitate the company’s capacity and market expansion, laying a foundation for subsequent commercial production of cancer-treatment products. Caution is noted under Rule 18A.05 of the Listing Rules, reminding shareholders and potential investors that there is no assurance the relevant product will ultimately be successfully developed or marketed.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TYK Medicines, Inc (Stock Code: 2410) Granted Drug Manufacturing License</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTYK Medicines, Inc (Stock Code: 2410) Granted Drug Manufacturing License\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-01-23 19:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TYK Medicines, Inc (浙江同源康醫藥股份有限公司) (Stock Code: 2410) announced that it has been granted the Drug Manufacturing License by the Drug Administration of Zhejiang Province. According to the announcement, the license carries the number “Zhejiang 20260002” and remains valid until January 22, 2031. The production address and range designate Asymchem Life Science (Tianjin) Co., Ltd. as trustee manufacturer at No. 71, 7th Street, Economic-Technological Development Area, Tianjin.</p>\n<p>The announcement indicates that securing this license may facilitate the company’s capacity and market expansion, laying a foundation for subsequent commercial production of cancer-treatment products. Caution is noted under Rule 18A.05 of the Listing Rules, reminding shareholders and potential investors that there is no assurance the relevant product will ultimately be successfully developed or marketed.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02410","symbol_name":"同源康医药-B","start_time":0,"source_url":"","article_id":"1156381147","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156381147","pubTimestamp":1769168676,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"TYK Medicines, Inc (浙江同源康醫藥股份有限公司) (Stock Code: 2410) announced that it has been granted the Drug Manufacturing License by the Drug Administration of Zhejiang Province. According to the announcement,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02410":"同源康医药-B"},"translate_title":"TYK Medicines，Inc（股份代号：2410）获授药品生产许可证","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02410":1},"content_text":"TYK Medicines, Inc (浙江同源康醫藥股份有限公司) (Stock Code: 2410) announced that it has been granted the Drug Manufacturing License by the Drug Administration of Zhejiang Province. According to the announcement, the license carries the number “Zhejiang 20260002” and remains valid until January 22, 2031. The production address and range designate Asymchem Life Science (Tianjin) Co., Ltd. as trustee manufacturer at No. 71, 7th Street, Economic-Technological Development Area, Tianjin.\nThe announcement indicates that securing this license may facilitate the company’s capacity and market expansion, laying a foundation for subsequent commercial production of cancer-treatment products. Caution is noted under Rule 18A.05 of the Listing Rules, reminding shareholders and potential investors that there is no assurance the relevant product will ultimately be successfully developed or marketed.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}